Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-...
Q2 2026
May 14, 2026
Q1 2026
Mar 17, 2026
FY 2025
Nov 10, 2025
Q4 2025
Q3 2025
Aug 14, 2025